We are live on
!
Find out more
Rafferty Asset Management Portfolio holdings
AUM
$24.6B
1-Year Est. Return
47.06%
This Fund
S&P 500
This Quarter
Est. Return
+7.87%
1 Year Est. Return
+47.06%
3 Year Est. Return
+108.18%
5 Year Est. Return
+135.84%
10 Year Est. Return
+427.13%
AUM
$15.9B
AUM Growth
+$1.24B
(+8.5%)
Cap. Flow
+$523M
Cap. Flow
% of AUM
3.3%
Top 10 Holdings %
Top 10 Hldgs %
35.05%
Holding
1,298
New
139
Increased
794
Reduced
319
Closed
45
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$228M |
| 2 |
KraneShares CSI China Internet ETF
KWEB
|
+$41.5M |
| 3 |
Xtrackers Harvest CSI 300 China A-Shares ETF
ASHR
|
+$35.7M |
| 4 |
Intel
INTC
|
+$34.7M |
| 5 |
Blackstone
BX
|
+$34.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
A10 Networks
ATEN
|
+$258M |
| 2 |
State Street SPDR S&P Oil & Gas Exploration & Production ETF
XOP
|
+$255M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$197M |
| 4 |
XLNX
Xilinx Inc
XLNX
|
+$83.7M |
| 5 |
iShares MSCI Brazil ETF
EWZ
|
+$35M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 33.02% |
| 2 | Financials | 19.16% |
| 3 | Energy | 5.34% |
| 4 | Healthcare | 4.01% |
| 5 | Industrials | 3.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
DMTK
551
DELISTED
DermTech, Inc. Common Stock
DMTK
| $2.67M | 0.02% |
64,330
+2,102
| +3% | +$86.3K |
|
|
KYNB
552
Kyntra Bio
KYNB
$27.5M
| $2.67M | 0.02% |
4,004
+213
| +6% | +$123K |
|
553
Etsy
ETSY
$7.89B
| $2.66M | 0.02% |
12,932
+3,392
| +36% | +$628K |
|
|
APLS
554
DELISTED
Apellis Pharmaceuticals
APLS
| $2.65M | 0.02% |
41,991
-29,421
| -41% | -$1.52M |
|
|
IMGN
555
DELISTED
Immunogen Inc
IMGN
| $2.65M | 0.02% |
402,546
+24,784
| +7% | +$173K |
|
556
BioMarin Pharmaceuticals
BMRN
$11.7B
| $2.65M | 0.02% |
31,783
-11,618
| -27% | -$921K |
|
|
GTHX
557
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
| $2.65M | 0.02% |
120,655
-22,042
| -15% | -$490K |
|
558
Cavco Industries
CVCO
$4.33B
| $2.64M | 0.02% |
11,900
+1,732
| +17% | +$377K |
|
559
Novavax
NVAX
$1.22B
| $2.64M | 0.02% |
12,439
-4,007
| -24% | -$734K |
|
|
BPMC
560
DELISTED
Blueprint Medicines
BPMC
| $2.64M | 0.02% |
30,014
-1,033
| -3% | -$94.7K |
|
|
AJRD
561
DELISTED
Aerojet Rocketdyne Holdings
AJRD
| $2.64M | 0.02% |
54,641
+9,065
| +20% | +$435K |
|
562
Heron Therapeutics
HRTX
$94.1M
| $2.63M | 0.02% |
169,383
-27,309
| -14% | -$434K |
|
563
Replimune Group
REPL
| $2.63M | 0.02% |
68,427
-29,605
| -30% | -$1.01M |
|
564
Curis
CRIS
$9.67M
| $2.63M | 0.02% |
814
+51
| +7% | +$230K |
|
|
MYOV
565
DELISTED
Myovant Sciences Ltd.
MYOV
| $2.63M | 0.02% |
+115,419
| New | +$2.43M |
|
566
Celldex Therapeutics
CLDX
$3.02B
| $2.63M | 0.02% |
78,501
-42,558
| -35% | -$1.17M |
|
567
Chord Energy
CHRD
$7.78B
| $2.62M | 0.02% |
+26,066
| New | +$2.14M |
|
568
Louisiana-Pacific
LPX
$5.02B
| $2.62M | 0.02% |
43,468
+5,281
| +14% | +$338K |
|
|
CLVS
569
DELISTED
Clovis Oncology, Inc.
CLVS
| $2.62M | 0.02% |
451,296
-109,628
| -20% | -$642K |
|
|
HZNP
570
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $2.62M | 0.02% |
27,962
+23,794
| +571% | +$2.19M |
|
571
CareDx
CDNA
$1.97B
| $2.62M | 0.02% |
28,587
-20,756
| -42% | -$1.65M |
|
|
SWTX
572
DELISTED
SpringWorks Therapeutics
SWTX
| $2.62M | 0.02% |
31,730
-10,715
| -25% | -$814K |
|
573
United Therapeutics
UTHR
$26.2B
| $2.61M | 0.02% |
14,565
-6,312
| -30% | -$1.2M |
|
574
Alibaba
BABA
$279B
| $2.61M | 0.02% |
11,511
-2,174
| -16% | -$483K |
|
575
Lazard
LAZ
$4.09B
| $2.61M | 0.02% |
57,673
+6,852
| +13% | +$314K |
|
Similar funds
CS
AF
SC
JG
Rafferty Asset Management's Q2 2021 Portfolio in Review
As of Q2 2021, Rafferty Asset Management held 1,298 positions worth $15.9B, up 8.5% from $14.6B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Rafferty Asset Management deployed $523M of net new capital in Q2 2021, opening 139 new positions and adding to 794 existing holdings. Its largest new stake was Blackstone: 386,473 shares worth $37.5M.
By sector, the portfolio is most concentrated in Technology at 33% of assets, down from 34% a quarter earlier, followed by Financials and Energy.
On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $197M trimmed.
- Rafferty Asset Management's largest Q2 2021 buy was Blackstone: 386,473 shares worth $37.5M.
- Rafferty Asset Management added most to iShares Core S&P 500 ETF in Q2 2021, an estimated $228M increase.
- Rafferty Asset Management's biggest Q2 2021 reduction was iShares Russell 2000 ETF, cutting an estimated $197M.
- Rafferty Asset Management fully exited A10 Networks in Q2 2021, selling an estimated $258M.
- Rafferty Asset Management's ten largest holdings make up 35% of its $15.9B portfolio in Q2 2021.
- Rafferty Asset Management opened 139 new positions and closed 45 in Q2 2021.
- Rafferty Asset Management's portfolio value rose 8.5% quarter-over-quarter to $15.9B.
Based on Rafferty Asset Management's 13F filing for Q2 2021, filed 10 Aug 2021.